ArticlePloS one2026
Molecular insights into heart field-specific cardiomyocyte differentiation - A computational study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding the mechanisms underlying cardiomyocyte (CM) differentiation is essential for the accurate generation of the different types of heart cells in vitro. This study advances current models of CM differentiation by introducing a gene regulatory network (GRN) model that integrates early heart field formation with downstream differentiation of committed cardiomyocytes into atrial and ventricular subtypes. The model is implemented using Boolean logic, enabling qualitative simulation of cardiac regulatory dynamics. Attractor analysis identifies steady states corresponding to first and second heart field derived atrial and ventricular cardiomyocytes. The model reveals the mechanism of WNT and BMP signaling in heart field determination and shows how RA regulation of NR2F2 decisively determines atrial versus ventricular cardiomyocyte cell fate. The model reproduced published knockout and overexpression experiments, and probabilistic simulations estimate differentiation efficiencies under varying signaling inputs. The unified Boolean model provides a foundation for generating heart-field-specific cardiomyocytes with precise atrial or ventricular identities, supporting efforts in directed differentiation and targeted heart cell therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.